Health News

Pharma co Boehringer Ingelheim partners with blockchain firm for diabetes care

diabetes drugs pharma medication
Yesterday blockchain healthcare firm Solve.Care announced it has partnered with Boehringer Ingelheim Pharmaceuticals Inc to create the Diabetes Care Administration Network. The digital network aims to streamline treatment for type 2 diabetes patients. The network will use an existing system, Solve.Care’s Care.Wallets, a blockchain based tool for managing US healthcare. The idea is to have insurance details, coverage, procedure costs, and healthcare provider communications in one place. The Estonia based firm’s technology will be applied to the type 2 diabetes-focused network to allow patients to coordinate their care with doctors and families easily.
The need
Yesterday’s announcement highlights the importance of the family connection. Solve.Care’s network hopes to connect not only physicians and patients but those closest to the patients. Hence, the burden of adhering to an often complicated diabetes treatment system does not fall on the sufferer alone.

Article continues …

subscriber padlock

Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.